These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7064134)

  • 1. Measurement of the heparin enhanced-antithrombin III/thrombin reaction rate in the presence of synthetic substrate.
    Griffith MJ
    Thromb Res; 1982 Feb; 25(3):245-53. PubMed ID: 7064134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulant and noncoagulant thrombin enzymatic activity on the endothelium.
    Frebelius S; Nydahl S; Swedenborg J
    Blood Coagul Fibrinolysis; 1990 Aug; 1(3):285-92. PubMed ID: 2103313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
    Elgue G; Blombäck M; Olsson P; Riesenfeld J
    Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of esterase and amidase activities of alpha- and beta-thrombin in the presence of antithrombin III and heparin.
    Borsodi A; Machovich R
    Biochim Biophys Acta; 1979 Feb; 566(2):385-9. PubMed ID: 570423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium inhibits the heparin-catalyzed antithrombin III/thrombin reaction by decreasing the apparent binding affinity of heparin for thrombin.
    Speight MO; Griffith MJ
    Arch Biochem Biophys; 1983 Sep; 225(2):958-63. PubMed ID: 6625618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of thrombin/antithrombin III reaction in the presence of protamine or polybrene.
    Oshima G
    Thromb Res; 1988 Sep; 51(6):565-74. PubMed ID: 3187966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods for semi micro or automated determination of thrombin, antithrombin, and heparin cofactor using he substrate, H-D-Phe-Pip-Arg-p-nitroanilide-2HCl.
    Scully MF; Kakkar VV
    Clin Chim Acta; 1977 Sep; 79(3):595-602. PubMed ID: 70286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The heparin-enhanced antithrombin III/thrombin reaction is saturable with respect to both thrombin and antithrombin III.
    Griffith MJ
    J Biol Chem; 1982 Dec; 257(23):13899-302. PubMed ID: 7142182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of monovalent cations on the heparin-enhanced antithrombin III/thrombin reaction.
    Griffith MJ; Beavers G; Kingdon HS; Lundblad RL
    Thromb Res; 1980 Jan 1-15; 17(1-2):29-39. PubMed ID: 7376137
    [No Abstract]   [Full Text] [Related]  

  • 10. A simple rate law that describes the kinetics of the heparin-catalyzed reaction between antithrombin III and thrombin.
    Nesheim ME
    J Biol Chem; 1983 Dec; 258(23):14708-17. PubMed ID: 6643505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of thrombin to thrombomodulin accelerates inhibition of the enzyme by antithrombin III. Evidence for a heparin-independent mechanism.
    Preissner KT; Delvos U; Müller-Berghaus G
    Biochemistry; 1987 May; 26(9):2521-8. PubMed ID: 3038185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrostatic interactions in the heparin-enhanced reaction between human thrombin and antithrombin.
    Petersen LC; Jørgensen M
    Biochem J; 1983 Apr; 211(1):91-7. PubMed ID: 6870832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assay of platelet factor 4(PF4) using synthetic thrombin substrates.
    Wohl H; Kujawa M; Prager L
    Thromb Res; 1978 Aug; 13(2):289-95. PubMed ID: 694846
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of heparin-catalyzed human antithrombin III activity by nonenzymatic glycosylation. Possible role in fibrin deposition in diabetes.
    Brownlee M; Vlassara H; Cerami A
    Diabetes; 1984 Jun; 33(6):532-5. PubMed ID: 6724150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the anticoagulant mechanisms of a covalent antithrombin-heparin complex.
    Berry L; Stafford A; Fredenburgh J; O'Brodovich H; Mitchell L; Weitz J; Andrew M; Chan AK
    J Biol Chem; 1998 Dec; 273(52):34730-6. PubMed ID: 9856996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the molecular mass dependency of heparin stimulation of heparin cofactor II:thrombin interaction to antithrombin III:thrombin interaction.
    Scully MF; Ellis V; Kakkar VV
    Thromb Res; 1987 May; 46(3):491-502. PubMed ID: 3603437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abolition by dextran sulfate of the heparin-accelerated antithrombin III/thrombin reaction.
    Oshima G; Nagai T; Nagasawa K
    Thromb Res; 1984 Sep; 35(6):601-11. PubMed ID: 6209818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic analysis of the heparin-enhanced antithrombin III/thrombin reaction. Reaction rate enhancement by heparin-thrombin association.
    Griffith MJ
    J Biol Chem; 1979 Dec; 254(23):12044-9. PubMed ID: 500693
    [No Abstract]   [Full Text] [Related]  

  • 19. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
    Weitz JI; Hudoba M; Massel D; Maraganore J; Hirsh J
    J Clin Invest; 1990 Aug; 86(2):385-91. PubMed ID: 2384594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of heparin, NaCl and CaCl2 on the rate of the thrombin-antithrombin III reaction.
    Machovich R; Regoeczi E; Hatton MW
    Thromb Res; 1979; 15(5-6):821-34. PubMed ID: 494181
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.